Our results revealed that inhibiting either Akt or mTOR via Triciribine and Rapamycin, respectively, would lead to a similar decrease in sphere formation ability in both glioblastoma and neuroblastoma cell lines. This evidence concerns the gene AKT1 and neuroblastoma.